Inactive Instrument

InterMune Inc Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

17/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE

17/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE
28/08/14	Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	RE
26/08/14	Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	RE
25/08/14	CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	RE
20/03/14	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
07/06/13	NVIDIA Corporation : SAC insider-trading probe could last years	RE
21/03/13	Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	RE
16/03/13	Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	RE
28/12/12	InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	RE
20/12/12	Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	RE
08/12/12	Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	RE
24/07/12	InterMune, Inc. : InterMune posts lower-than-expected revenue	RE

02/10/14	InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	PU
20/09/14	InterMune : Reports Memorandum of Understanding in Connection with Consolidated Delaware Action	PR
05/09/14	InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	PR
28/08/14	InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
27/08/14	InterMune : INVESTOR ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG	BU

04/09/14	Roche : exclut une mega-fusion, ouvert à de plus petits rachats
26/08/14	Wall Street finit dans le vert, le S&P passe un cap
25/08/14	Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P
25/08/14	Wall Street ouvre en hausse avec les M&A et l'Europe
25/08/14	Apple : USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Edward Harrington CEO	Chief Executive Officer	-	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	71	01/04/2002
Carla Fiankan LAW	General Counsel	-	01/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-0.56%	-8.08%	-3.88%	+10.58%	46.38B
REVOLUTION MEDICINES, INC.	-2.08%	-3.57%	+402.72%	+533.09%	44.51B
IQVIA HOLDINGS INC.	+0.12%	-5.27%	+39.94%	+20.50%	42.3B
BEONE MEDICINES AG	-2.62%	-5.76%	+8.88%	+77.44%	39.91B
CELLTRION, INC.	-1.26%	-3.37%	+11.87%	+40.55%	32.79B
ASCENDIS PHARMA A/S	+0.16%	-3.65%	-	-	17.13B
MEDPACE HOLDINGS, INC.	-0.54%	-1.72%	+22.34%	+115.10%	16.36B
EUROFINS SCIENTIFIC SE	-0.03%	-3.46%	+12.68%	+30.90%	14.31B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.92%	-6.94%	+78.12%	+36.68%	13.29B
Average	-0.97%	-4.30%	+71.58%	+108.10%	29.66B
Weighted average by Cap.	-1.09%	-4.54%	+87.11%	+129.36%